糖酵解
胶质母细胞瘤
柠檬酸合酶
表型
谷氨酸受体
转氨酶
丙酮酸羧化酶
癌症研究
医学
生物
内科学
生物化学
新陈代谢
酶
基因
受体
作者
Tianchi Tang,Yang Liu,Min Yang,Ming Tu,Wanchun Zhu,Ming Chen
标识
DOI:10.1016/j.wneu.2021.07.097
摘要
Glycolysis is an important metabolic manner in glioblastoma multiforme (GBM)'s rapid growth. It has been reported that glutamate-oxaloacetate transaminase 1 (GOT1) is low-expressed in GBM and patients with high-expressed GOT1 have better prognosis. However, the effect and mechanism of GOT1 on glycolysis and malignant phenotypes of GBM cells are still unclear.The expression differences of GOT1 between GBM parenchyma and adjacent tissues were detected. The prognosis and clinical data with different levels of GOT1 were also analyzed. The glucose consumption, production of lactate and pyruvate were measured after GOT1 was knocked down or overexpressed. The effects of GOT1 on GBM cell's malignant phenotypes were analyzed by Western blot, CCK-8 assay, and flow cytometry. The relationship between GOT1 and pyruvate carboxylase (PC) was examined by immunoprecipitation and immunofluorescence.GOT1 was expressed little in GBM, and patients with highly expressed GOT1 had longer survival periods. Overexpressed GOT1 inhibited the glycolysis and malignant phenotypes of GBM cells. 2-DG treatment could partially reverse the enhancement of malignant phenotypes caused by knockdown of GOT1. The expression of GOT1 was positively correlated with PC. The inhibitory effect of GOT1 on glycolysis could be partially reversed by PC's knockdown.GOT1 could impair glycolysis by interacting with PC and further inhibit the malignant phenotypes of GBM cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI